Phosphorylation of WRN by CDK1 is not required for the initial processing of the DSB, but is crucial to sustain the subsequent long-range end resection, corroborating previous evidence for a role ...

You can see how its cash balance has changed over time in the image below. TSX:WRN Debt to Equity History August 11th 2024 ... Initial Jobless Clm. May 1, 2025, 8:30 AM EDT. Prior: P: 222 .

SAN DIEGO & BERLIN, Germany, June 04, 2025--Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG ...

image: ISM2196 is a novel, potent WRN inhibitor, designed with the assistance of Alchemistry, one of the latest modules of Chemistry 42. view more . Credit: Insilico Medicine ...